ClinicalTrials.Veeva

Menu
F

Frenova Renal Research | Renal Associates of Baton Rouge, LLC

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Bardoxolone Methyl
LNP023
VX-147
BI 685509

Parent organization

This site is a part of Frenova Renal Research

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 4 total trials

Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1- Mediated Proteinuric Kidney Disease (AMPLITUDE)

The purpose of this study is to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants...

Enrolling
Proteinuric Kidney Disease
Drug: Placebo
Drug: VX-147

The study is designed as a multicenter, randomized, double-blind, placebo controlled study to demonstrate the superiority of iptacopan (LNP023) at a...

Active, not recruiting
IgA Nephropathy
Drug: Placebo
Drug: LNP023

Trial sponsors

Boehringer Ingelheim logo
Novartis logo
Reata Pharmaceuticals logo
Vertex Pharmaceuticals logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems